10:44 AM EST, 12/20/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) said Friday it has priced an offering of shares and and pre-funded warrants to raise $40 million.

Monopar said it priced the underwritten registered offering of 798,655 shares at $23.79 per share and the private placement of warrants to purchase 882,761 shares at $23.789 per pre-funded warrant.

The offering is set to close Monday, with Piper Sandler as the book-running manager, the clinical-stage company. It plans to use the proceeds for general corporate purposes and working capital.

Monopar shares were up about 2% in recent trading.

Price: 24.29, Change: +0.50, Percent Change: +2.09